Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001761109 | SCV001998679 | uncertain significance | not provided | 2019-09-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31983221) |
Ambry Genetics | RCV002405305 | SCV002710071 | uncertain significance | Cardiovascular phenotype | 2021-07-23 | criteria provided, single submitter | clinical testing | The p.S526L variant (also known as c.1577C>T), located in coding exon 11 of the DSC2 gene, results from a C to T substitution at nucleotide position 1577. The serine at codon 526 is replaced by leucine, an amino acid with dissimilar properties. This alteration has been reported in a dilated cardiomyopathy (DCM) cohort; however, clinical details were limited (Mazzarotto F et al. Circulation, 2020 02;141:387-398). This amino acid position is not well conserved in available vertebrate species, and leucine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Invitae | RCV003517345 | SCV004285444 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2023-03-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DSC2 protein function. ClinVar contains an entry for this variant (Variation ID: 1311888). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 31983221). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 526 of the DSC2 protein (p.Ser526Leu). |
All of Us Research Program, |
RCV004009017 | SCV004829453 | uncertain significance | Familial isolated arrhythmogenic right ventricular dysplasia | 2023-12-13 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with leucine at codon 526 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with dilated cardiomyopathy (PMID: 31983221). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |